发明名称 NOVEL COMPOUNDS
摘要 Compounds of formula (I);;wherein R1 is 2-indanyl, R2 is 1-methylpropyl, R3 is a group selected from 2,6-dimethyl-3-pyridyl or 4,6-dimethyl-3-pyridyl, R4 represents methyl and R5 represents hydrogen or methyl or, R4 and R5 together with the nitrogen atom to which they are attached represent morpholino and pharmaceutically acceptable derivatives thereof are described, as are processes for their preparation, pharmaceutical compositions containing them and their use in medicine, particularly their use as oxytocin antagonists.
申请公布号 US2016030442(A1) 申请公布日期 2016.02.04
申请号 US201514881322 申请日期 2015.10.13
申请人 Glaxo Group Limited 发明人 Borthwick Alan David;Hickey Deirdre Mary Bernadette;Liddle John;Mason Andrew McMurtrie
分类号 A61K31/5377 主分类号 A61K31/5377
代理机构 代理人
主权项 1. A method of treating dysmenorrea which comprises administration to a human in need thereof (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione or a pharmaceutically acceptable salt thereof.
地址 Brentford GB